Pharmacokinetic and pharmacodynamic studies with a new controlled-release formulation of propranolol in normal volunteers: a comparison with other commercially available formulations.
暂无分享,去创建一个
R. Grimaldi | E. Perucca | S. Lecchini | G. Gatti | F. Crema | G. Frigo | M. Caravaggi
[1] E. Perucca,et al. Plasma concentrations of propranolol and 4-hydroxy-propranolol at steady-state in neurological patients: intersubject and intrasubject correlations with dose. , 1984, International journal of clinical pharmacology research.
[2] A. Breckenridge,et al. The pharmacodynamics and pharmacokinetics of conventional and long-acting propranolol in patients with moderate hypertension. , 1983, British journal of clinical pharmacology.
[3] J. Parker,et al. Propranolol in angina pectoris. Comparison of long-acting and standard-formulation propranolol. , 1982, Circulation.
[4] D. Wynford‐Thomas,et al. A study of long acting propranolol in the early management of hyperthyroidism. , 1981, British journal of clinical pharmacology.
[5] E. Raftery,et al. Propranolol LA and ambulatory blood pressure. , 1980, British journal of clinical pharmacology.
[6] J. Remon,et al. An improved extraction procedure for the liquid chromatographic determination of propranolol and 4-hydroxypropranolol in plasma. , 1980, British journal of clinical pharmacology.
[7] J. Webster,et al. Atenolol, sustained-release oxprenolol, and long-acting propranolol in hypertension. , 1980, British medical journal.
[8] R. Shanks,et al. Comparison of the efficacy and pharmacokinetics of conventional propranolol and a long acting preparation of propranolol. , 1980, British journal of clinical pharmacology.
[9] P. Routledge,et al. Clinical Pharmacokinetics of Propranolol , 1979, Clinical pharmacokinetics.
[10] N. Baber,et al. Pharmacokinetic and pharmacodynamic studies with long-acting propranolol. , 1978, British journal of clinical pharmacology.